NCT04015726

Brief Summary

The prevalence of cardiometabolic risk is high among South Asians which manifests itself at an early age. Studies have reported that unhealthy food choices, inadequate physical activity and lack of awareness on healthy lifestyle practices pose a huge threat to the increasing prevalence of metabolic abnormalities even at adolescence. In an earlier study conducted in 2006, reported that 68% of the children during their early adolescence had one or more of the cardiometabolic abnormalities such as obesity, central adiposity, increased blood pressure and presence of dysglycaemia and dyslipidaemia. The risk escalated with increasing weight. Therefore, it is imperative to sensitize the children on improving their lifestyle by conducting screening tests and health education programmes in schools by involving teachers. The Investigator have also shown in a study that teachers can be instrumental in imparting knowledge on the prevention of non-communicable diseases such as diabetes by promoting healthy behavioral changes. The proposed study will focus on a) changes in the prevalence of cardiometabolic risk factors over a 10 year period b) health education programme to school children c) recommendations to school teachers (tool-kit) to inculcate improved lifestyle practices to their students.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,815

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 11, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 24, 2020

Status Verified

November 1, 2020

Enrollment Period

2.1 years

First QC Date

June 29, 2019

Last Update Submit

November 22, 2020

Conditions

Outcome Measures

Primary Outcomes (5)

  • Prevalence of central adiposity

    Among adolescent children in 2019 in comparison with 2006 data

    baseline

  • Prevalence of dysglycemia

    Among adolescent children in 2019 in comparison with 2006 data

    Baseline

  • Prevalence of dyslipidemia

    Among adolescent children in 2019 in comparison with 2006 data

    Baseline

  • Prevalence of hypertension

    Among adolescent children in 2019 in comparison with 2006 data

    Baseline

  • Prevalence of insulin resistance

    Among adolescent children in 2019 in comparison with 2006 data

    Baseline

Secondary Outcomes (4)

  • Prevalence of overweight

    Baseline

  • Prevalence of obesity

    Baseline

  • Changes in diet habit

    Baseline

  • Changes in duration of physical activity

    Baseline

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children both boys and girls between 12 - 18yrs age group

You may qualify if:

  • Children both boys and girls between 12 - 18yrs age group
  • Parents and child willing to give informed consent
  • Children must be available for and willing to attend all evaluation visits
  • Willingness to follow the protocol requirements as evidenced by written informed consent

You may not qualify if:

  • Children below the age of 12 years and above the age of 18 years
  • Parents or Child who is not willing to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

India Diabetes Research Foundation

Chennai, Tamil Nadu, 600008, India

RECRUITING

MeSH Terms

Conditions

ObesityDyslipidemiasHypertensionInsulin Resistance

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsLipid Metabolism DisordersMetabolic DiseasesVascular DiseasesCardiovascular DiseasesHyperinsulinismGlucose Metabolism Disorders

Study Officials

  • Ambady Ramachandran, MD, PhD, DSc

    Senior Research Officer

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ambady Ramachandran, MD, PhD, DSc

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2019

First Posted

July 11, 2019

Study Start

August 1, 2019

Primary Completion

August 31, 2021

Study Completion

December 31, 2021

Last Updated

November 24, 2020

Record last verified: 2020-11

Locations